- Home
- PTGX vs LION Comparison
PTGX vs LION Comparison
Compare PTGX & LION Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTGX
- LION
- Stock Information
- Founded
- PTGX 2006
- LION 1997
- Country
- PTGX United States
- LION Canada
- Employees
- PTGX N/A
- LION N/A
- Industry
- PTGX Biotechnology: Pharmaceutical Preparations
- LION Movies/Entertainment
- Sector
- PTGX Health Care
- LION Consumer Discretionary
- Exchange
- PTGX Nasdaq
- LION Nasdaq
- Market Cap
- PTGX 2.8B
- LION 2.0B
- IPO Year
- PTGX 2016
- LION N/A
- Fundamental
- Price
- PTGX $47.02
- LION $6.67
- Analyst Decision
- PTGX Strong Buy
- LION Strong Buy
- Analyst Count
- PTGX 7
- LION 3
- Target Price
- PTGX $52.83
- LION $11.83
- AVG Volume (30 Days)
- PTGX 695.3K
- LION 179.1K
- Earning Date
- PTGX 10-31-2024
- LION 11-07-2024
- Dividend Yield
- PTGX N/A
- LION N/A
- EPS Growth
- PTGX N/A
- LION N/A
- EPS
- PTGX 2.75
- LION N/A
- Revenue
- PTGX $319,120,000.00
- LION $2,949,800,000.00
- Revenue This Year
- PTGX $400.33
- LION $11.34
- Revenue Next Year
- PTGX N/A
- LION $7.19
- P/E Ratio
- PTGX $17.11
- LION N/A
- Revenue Growth
- PTGX 125.73
- LION N/A
- 52 Week Low
- PTGX $13.72
- LION $6.13
- 52 Week High
- PTGX $48.32
- LION $12.84
- Technical
- Relative Strength Index (RSI)
- PTGX 61.71
- LION 40.12
- Support Level
- PTGX $43.18
- LION $6.54
- Resistance Level
- PTGX $48.32
- LION $7.06
- Average True Range (ATR)
- PTGX 1.41
- LION 0.26
- MACD
- PTGX 0.15
- LION -0.04
- Stochastic Oscillator
- PTGX 76.49
- LION 17.81
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
About LION Lionsgate Studios Corp. Common Shares
Lionsgate Studios Corp is a company encompasses world-class motion picture and television studio operations and the STARZ-branded premium global subscription platforms to bring a unique and varied portfolio of entertainment to consumers around the world. The Studio Business consists of the Motion Picture and Television Production reportable segments, together with substantially all of Lionsgate's corporate general and administrative costs. Motion Picture consists of the development and production of feature films, acquisition of North American and worldwide distribution rights. Television Production consists of the development, production and worldwide distribution of television productions including television series, television movies and mini-series, and non-fiction programming.